Quick Answer
Xenetic Biosciences, Inc. reported Research And Development Expense of $3.07 million for the year ending 2025.
- Xenetic Biosciences, Inc. showed a decrease of -6.8% in Research And Development Expense from 2024 to 2025.
- This data is from Xenetic Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Xenetic Biosciences, Inc.'s Research And Development Expense has declined by 0.5%.
- Historical annual values: Fiscal year 2025: $3.07 million | Fiscal year 2024: $3.29 million | Fiscal year 2023: $3.49 million | Fiscal year 2022: $4.77 million | Fiscal year 2021: $3.16 million | Fiscal year 2020: $1.73 million | Fiscal year 2019: $4.89 million | Fiscal year 2018: $2.88 million | Fiscal year 2017: $4.06 million | Fiscal year 2016: $43.74 million | Fiscal year 2015: $3.43 million | Fiscal year 2014: $6.32 million | Fiscal year 2013: $3.08 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: